anonymous
Guest
anonymous
Guest
Thanks for this info. How is it being perceived so far by physicians if anything? Should I also be hesitant it’s not approved by the FDA yet? I know it’s pending with possibly September approval. I know bigger companies tend to higher a ton of reps for a launch then within a year or two can be let go. I know that can be with any company but bigger companies have that reputation.This medication is in an entirely new class by itself. Doctors tend to prescribe many drugs in the same class (polypharmacy) when symptoms aren't fully controlled. This would most likey be used as an add-on to first/second gen antipsychotics. Its not intended to replace the first line drugs. So the fact that its BID vs daily doesn't make a huge difference as its a second line agent.